Tag: KAIST
-
AI-Optogenetics Platform for Early Parkinson’s Diagnosis and Therapy
A Groundbreaking Platform: AI Meets Optogenetics KAIST researchers have unveiled a pioneering preclinical platform that fuses artificial intelligence (AI) with optogenetics to advance both the diagnosis and treatment of Parkinson’s disease. The announcement, made by KAIST president Kwang Hyung Lee on September 22, highlights a collaboration spanning the university’s Biological Sciences, Brain and Cognitive Sciences,…
-
AI-Optogenetics Platform Bridges Early Parkinson’s Diagnosis and Therapy
A New AI-Optogenetics Platform for Parkinson’s A breakthrough in Parkinson’s disease research emerged from a Korean collaboration that fuses artificial intelligence with optogenetics. Announced by KAIST on September 22, the study brings together the expertise of Professor Won Do Heo (Department of Biological Sciences), Professor Daesoo Kim (Department of Brain and Cognitive Sciences), and Director…
-
AI-Optogenetics Platform for Parkinson’s Diagnosis and Therapy
Breakthrough: AI meets optogenetics for Parkinson’s diagnosis and treatment A pioneering preclinical platform from a Korean team at KAIST merges artificial intelligence with optogenetics to transform how Parkinson’s disease (PD) is diagnosed and therapeutically evaluated. The researchers, guided by Prof. Won Do Heo, Prof. Daesoo Kim, and Director Chang-Jun Lee, spotlight a path that could…